Report Overview
An Injectable Bone Graft is a type of medical treatment that involves injecting a special type of bone material or composite into the body to help repair or regenerate damaged bone tissue.
The major global companies of Injectable Bone Graft include Medtronic, DePuy Synthes, Baxter, Stryker (Wright Medical), BONESUPPORT, Xtant Medical, SeaSpine, Zimmer Biomet, and Biocomposites, etc. In 2023, the world's top three vendors accounted for approximately 43.09% of the revenue.
Market Analysis
The global Injectable Bone Graft Market was valued at US$ 674.13 million in 2023 and is anticipated to reach US$ 952.06 million by 2030, witnessing a CAGR of 5.15% during the forecast period 2024-2030.
North American market for Injectable Bone Graft is estimated to increase from $ 500.94 million in 2023 to reach $ 707.96 million by 2030, at a CAGR of 5.20% during the forecast period of 2024 through 2030.
